Latest News in the pharma Industry

Research & Development

Amgen To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab

Amgen To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab

13 Nov 2014

Read more 
First Wave of Phase III Development Programme for Grazoprevir/Elbasvir is Fully Enrolled; Merck Plans to Submit NDA in 2015

First Wave of Phase III Development Programme for Grazoprevir/Elbasvir is Fully Enrolled; Merck Plans to Submit NDA in 2015

13 Nov 2014

Read more 
Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase III Study Of Brodalumab

Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase III Study Of Brodalumab

12 Nov 2014

Read more 
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma

Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma

11 Nov 2014

Read more